Show simple item record

dc.contributor.authorWinarso, Hudi
dc.date.accessioned2020-04-20T08:59:45Z
dc.date.available2020-04-20T08:59:45Z
dc.date.issued2018-04
dc.identifier.urihttp://dspace.uc.ac.id/handle/123456789/2554
dc.description.abstractMale hypogonadism is a condition in which the body doesn’t produce enough testosterone- the hormone that plays a key role in masculine growth and development during puberty – or has an impaired ability to produce sperm or both. There are two basic types of hypogonadism : - Primary. The type of hypogonadism – also known as primary testicular failure – originates from a problem in the testicles. - Secondary. This type of hypogonadism indicates a problem in the hypothalamus or the pituitary gland – parts of the brain that signal the testicles to produce testosterone. Primary hypogonadism is associated with low levels of testosterone and high-normal to high levels of LH and FSH. For the diagnosis of primary hypogonadism, FSH measurement is partially important because FSH has a longer half life, is more sensitive, and demonstrates less variability than LH In case of primary hypogonadism in pre pubertal male, life-long testosterone treatment is needed. Treatment is initiation of therapy with small doses of testosterone (50 – 100 mg IM) every 3 or 4 weeks at the appropriate psychosocial stage in development. When a final adult height is thought to have been obtained, the adult dose of testosterone replacement is inaugurated.en_US
dc.language.isootheren_US
dc.publisherPERSANDI (Perhimpunan Dokter Spesialis Andrologi Indonesia)en_US
dc.subjectHypogonadism, genetic, hormonalen_US
dc.titleEvaluation for Primary Hypogonadismen_US
dc.typeOtheren_US


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record